Table 2 Sample description
Phenotype | Sample | Source | Ethnicity | Imputation reference panel | N |
---|---|---|---|---|---|
LRAs | ALSPAC | General population | White European | HRC r1.1 | ≤5891 |
ADHD | PGC | Clinical sample | Predominantly white European | HapMap phase 3 | 16,203 (Ncases = 4163) |
ADHD | iPSYCH | Clinical sample | White European | 1000 Genomes phase 3 | 37,076 (Ncases = 14,584) |
ADHD | PGC + iPSYCH (EUR) | Clinical sample | White European | 1000 Genomes phase 3 | 53,293 (Ncases = 19,099) |
ADHD | PGC + iPSYCH | Clinical sample | Predominantly white European | 1000 Genomes phase 3 | 55,374 (Ncases = 20,183) |
EA | SSGAC | Predominantly general population | White European | 1000 Genomes phase 3a | 326,041 |